Inhibitor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17	10	16	37	56	13
Market Cap Growth	-22.06%	-34.56%	-57.47%	-34.06%	332.17%	-36.77%
Enterprise Value	15	4	6	42	61	17
Last Close Price	0.10	0.06	0.09	0.10	0.15	0.03
PE Ratio	-	-	-	3.12	-	-
PB Ratio	5047.76	5.22	3.00	4.49	-15.59	-3.89
P/TBV Ratio	5047.76	5.22	3.00	4.49	-	-
P/OCF Ratio	-	-	-	3.17	-	-
Debt / Equity Ratio	20.75	-	-	0.05	-0.06	-0.03
Net Debt / Equity Ratio	-841.30	-2.82	-1.67	-1.39	-0.05	-0.01
Quick Ratio	34.01	7.90	13.29	17.61	0.05	0.18
Current Ratio	35.01	8.03	13.45	17.64	0.09	0.25
Return on Equity (ROE)	-200.97%	-91.88%	-44.57%	517.86%	-	-
Return on Assets (ROA)	-46.88%	-31.22%	-20.34%	-6.83%	-213.47%	-128.30%
Return on Capital Employed (ROCE)	-118.00%	-73.40%	-41.10%	-5.80%	52.40%	360.60%
Earnings Yield	-19.66%	-32.24%	-19.12%	32.53%	-0.53%	-8.10%
Buyback Yield / Dilution	-0.15%	-0.18%	53.04%	2.67%	-1.16%	-0.40%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.